The activation of phagocytic leukocytes by LPS has been implicated in the pathogenesis of Gram-negative sepsis. The identification of CD14 as a mediator of LPS-inducible signal transduction was a crucial event in understanding the mechanism by which LPS-induced cellular activation occurs. CD14, a 55 kDa glycosyl phosphatidylinositol (GPI)-linked protein present on the surface of phagocytic leukocytes, has been shown to bind LPS and to mediate cellular activation. While it is generally agreed that the interaction between lipid A and CD14 is central to cellular activation by LPS, details of the downstream events which follow remain obscure. The CD11/CD18 integrins are a second group of LPS receptors. The observation that CD11/CD18 could enable LPS responsiveness independent of CD14 when expressed on the surface of CHO cells suggested that the ability of CD14 to participate in the LPS signaling cascade was not unique. We hypothesized that the common function shared by these two LPS receptors was their ability to bind LPS and bring it in close proximity to the plasma membrane, where it could then interact with a signal transducer. To further investigate the role of LPS binding in cellular signaling, we decided to exploit the activity of two other proteins known to bind LPS: lipopolysaccharide binding protein (LBP) and bactericidal/permeability-increasing protein (BPI). We found that when these normally soluble proteins were expressed in a CHO-K1 fibroblast as a GPI-anchored receptor, both could substitute for CD14 in initiating the nuclear translocation of NF-κB in response to LPS stimulation. Pharmacological studies with an LPS antagonist demonstrated that these artificial LPS receptors had characteristics that were qualitatively identical to CD14. These data support the hypothesis that a receptor distinct from CD14 functions as the actual signal transducer, and suggests that surface binding of LPS to the cell membrane is the crucial first step in initiation of the downstream signaling events. We conclude that any LPS binding protein that can focus LPS on the cell surface is sufficient to activate cells.
Read full abstract